ClinicalTrials.govpublic full text
Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
cure rate of helicobacter pylori infection
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 366625
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.